Sanofi Consumer Healthcare India reports robust Q4 and FY’25 growth
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
The company reported a 28% year-on-year increase in Q2 revenue to Rs. 220.9 crore
The Q1 2025 also witnessed a successful launch of Allegra D
Himanshu brings with him a wealth of rich experience from commercial, marketing, and general management roles
His most recent stint was with Danone India as its Managing Director
The proposed combination involves corporate restructuring of JVCO, including through acquisition by Haleon via demerger
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The company said Revital NXT is India’s first nutrition bar with the goodness of natural ginseng, 16 vitamins & minerals and triple blend protein
Cadila Pharmaceuticals’ journey has been marked by several milestones, including the development of indigenous formulations, expansion into global markets, and the creation of robust manufacturing and R&D capabilities
Subscribe To Our Newsletter & Stay Updated